IREN vs. VRNA

Last updated Jun 13, 2026

IREN (IREN Limited) and VRNA (Verona Pharma plc) are both stocks. IREN operates in Capital Markets (Financial Services), while VRNA operates in Biotechnology (Healthcare). At a 0.18 correlation, their price movements are largely independent.

Performance

IREN vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IREN Limited (IREN) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

IREN

• 1D: 5.40%
• 1M: 12.90%
• YTD: 58.25%
• 6M: 48.94%
• 1Y: 508.04%
• 3Y*: 155.58%
• 5Y*: —
• 10Y*: —

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IREN vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
IREN IREN Limited	58.25%	284.62%	37.34%	472.00%	-92.27%	-42.25%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	26.08%

Correlation

The correlation between IREN and VRNA is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.08
Correlation (3Y) Calculated over the trailing 3-year period	0.17
Correlation (All Time) Calculated using the full available price history since Nov 17, 2021	0.18

The correlation between IREN and VRNA shifts across timeframes, from 0.08 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS IREN : $0.45 VRNA : -$0.69
PS Ratio IREN : 13.39 VRNA : 57.97
Total Revenue (TTM) IREN : $757.07M VRNA : $167.65M
Gross Profit (TTM) IREN : $433.88M VRNA : $159.52M
EBITDA (TTM) IREN : -$173.05M VRNA : -$40.86M

Return for Risk

IREN vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IREN

IREN Risk / Return Rank: 95
IREN Sharpe Ratio Rank: 99
IREN Sortino Ratio Rank: 94
IREN Omega Ratio Rank: 91
IREN Calmar Ratio Rank: 97
IREN Martin Ratio Rank: 94

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IREN vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IREN Limited (IREN) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IREN	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	4.76	—	—
Sortino ratio: Return per unit of downside risk	3.66	—	—
Omega ratio: Gain probability vs. loss probability	1.42	—	—
Calmar ratio: Return relative to maximum drawdown	8.39	—	—
Martin ratio: Return relative to average drawdown	15.97	—	—

Drawdowns

Drawdown Indicators

	IREN	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-96.21%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-58.62%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-65.56%	—	—
Current Drawdown Current decline from peak	-21.78%	—	—
Average Drawdown Average peak-to-trough decline	-65.42%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	30.74%	—	—

Volatility

Volatility by Period

	IREN	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	34.10%	—	—
Volatility (6M) Calculated over the trailing 6-month period	75.79%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	103.25%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	118.61%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	118.61%	—	—

Dividends

IREN vs. VRNA - Dividend Comparison

Neither IREN nor VRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both IREN and VRNA in my portfolio?

IREN and VRNA have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.